Medicine & Health

WashU Medicine researchers led by Michael E. Belloy (left), an assistant professor of neurology and of psychiatry, identified key genetic targets for potential Alzheimer’s disease therapeutics development.

A movie trailer, local TV spot and documentaries produced by WashU Medicine Marketing & Communications recently won medals in the Telly awards, an international contest honoring excellence in TV and video production.

WashU Medicine researchers led a clinical trial testing three diets with different proportions of fat and carbohydrates and found all of them improved metabolic health, but a ketogenic plan had additional benefits for liver health and blood sugar control.

Jennifer Layden of Bursky Public Health explains conflicting childhood vaccine guidance, drawing on her experience leading state outbreak responses and national vaccination efforts at the CDC.

Biologist Keith Hengen, in WashU Arts & Sciences, is applying lessons from the brain to next-generation quantum sensors through a U.S. Department of Energy-funded project.

New research from the lab of WashU McKelvey Engineering’s Srikanth Singamaneni shows the early success of a microneedle patch that can be applied on the skin to capture biomarkers of kidney injury. It may one day support home or point-of-care monitoring.

The biomarker test, called PrecivityAD2, was developed from technology invented at WashU Medicine by Randall J. Bateman, MD, and David M. Holtzman, MD.

For low-income older adults, where they live may affect how long they live, according to new research from Washington University in St. Louis.

From longer lives to eroding institutional trust, powerful forces are converging in ways that demand new approaches to protecting human health.

Nathan Stitziel, MD, PhD, has received a $1.9 million grant from the Leducq Foundation to help lead an international collaboration aimed at identifying new therapeutic targets for cardiovascular disease and improving prevention.